7 June 2015 marked the start of a joint European project in Halle intended to shed light on common molecular features in the early development of neurodegenerative diseases. Five partner institutions from Halle, Leipzig, Erlangen, Paris (France) and Oslo (Norway) have set themselves the goal of working on therapeutic strategies based on new findings. The project, which is set to run over a three-year period, has been awarded a total of 1.7 million euros in funding from the European Union.
Besides the devastating effects they have on patients, neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases have one key thing in common: their pathology is based on the aggregation and accumulation of misfolded proteins in the brain.
This results in a loss of tissue and function and, consequently, severe neurological disorders which are fatal in the advanced stages of the diseases. Until now, the mechanisms associated with the early development of these diseases have mainly been researched independently of each other.
Latest investigations, however, have suggested similarities in the molecular development processes of the diseases. This is centered around the hypothesis that misfolded peptides, which frequently arise in the case of such diseases, also induce a deposit of other proteins.
This means that a peptide triggers degenerative processes which become more intense through the coaggregation of peptides. The main target proteins to be investigated include Abeta, alpha-synuclein and huntingtin.
Fraunhofer IZI's Molecular Drug Biochemistry and Therapy Development (MWT) project group is coordinating the EU project and aims to research these common features and develop new therapeutic strategies.
Led by Professor Hans-Ulrich Demuth and Dr Stephan Schilling, the group will contribute their many years of experience researching misfolded proteins to the project. Consequently, the Halle scientists have set themselves the chief task of synthesizing respective proteins and antibodies for their subsequent investigation. At Leipzig University, detailed investigations into the development of Alzheimer's will then be carried out building on this research.
At the Friedrich-Alexander University Erlangen-Nürnberg, the focus is placed on research into Huntington's disease, while the French National Institute of Health and Medical Research in Paris will look at the development of Parkinson's disease with an eye to the aspects mentioned above. At the University of Oslo, a computer-based database will be created, which will draw on the histological data generated by the units in order to gain a corresponding, local correlation between protein deposits in the brain for each different disease model.
Information on funding
This project is being funded by the "EU Joint Programme – Neurodegenerative Disease Research (JPND)", the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase the coordinated investments of its partner countries and thus to support research which looks to identify causes of disease, therapy development and suitable care measures for patients. Further information can be found at: www.jpnd.eu
Presse Institute | Fraunhofer-Gesellschaft
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences